
原料药
Sildenafil Citrate
KDMF APIs
Sildenafil Citrate
韩文名称 | 실데나필시트르산염 |
|---|---|
分类 | 泌尿生殖系统及肛门用药 |
CAS No. | 171599-83-0 |
KDMF 登记号 | 20200602-211-J-644 |
生产厂商 | Mylan Laboratories Limited |
规格 | EP |
品目信息
IUPAC Name | Piperazine,1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methyl-,2-hydroxy-1,2,3-propanetricarboxylate (1:1) |
|---|---|
Synonyms | 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate (1:1) 5-[2-ethoxy-5-(4-methylpiperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one citrate 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate |
Description | When NO is locally released from sexual stimulation, sildenafil inhibits PDE5 and increases the amount of cGMP in the corpus cavernosum, which relaxes smooth muscles and increases blood flow into the corpus cavernosum, producing an erection. Recommended dose of sildenafil has no effect in the absence of sexual stimulation. PDE5 is present in other tissues including platelets, abdominal smooth muscle, skeletal muscle, which may be the basis for inhibition of platelet thrombogenesis and peripheral arteriovenous dilatation. |
Certificate of Analysis | If you need more information, please contact us. |
如需规格书 · 检验成绩书等附加资料,请在咨询时一并提出。负责人确认后将回复您。(02-579-1056 · ace@acebiopharm.com)